CRM
PRAH

Cramer Rosenthal McGlynn’s PRA Health Sciences, Inc. PRAH Stock Holding History

Cramer Rosenthal McGlynn’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-686,200
Closed -$19.8M – 245
2015
Q1 		$19.8M Sell
686,200
-68,000
-9% -$1.9M 0.22% 132
2014
Q4 		$18.3M Buy
+754,200
New +$17M 0.19% 131

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Cramer Rosenthal McGlynn's PRAH Position: Q2 2015 in Review

Cramer Rosenthal McGlynn sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2015, closing a stake of 686,200 shares — an estimated $19.8M sold.

Cramer Rosenthal McGlynn first reported a position in PRAH in Q4 2014 and held it in 2 quarters. The position peaked at $19.8M in Q1 2015. 94 funds tracked by Wall St. Rank hold PRAH as of Q2 2015.

  • Cramer Rosenthal McGlynn reported no remaining PRA Health Sciences, Inc. position as of Q2 2015 after selling out during the quarter.
  • Cramer Rosenthal McGlynn sold 686,200 PRA Health Sciences, Inc. shares in Q2 2015, an estimated $19.8M.
  • Cramer Rosenthal McGlynn first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 2 quarters.
  • Cramer Rosenthal McGlynn's PRA Health Sciences, Inc. position peaked at $19.8M in Q1 2015.
  • 94 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2015.

Based on Cramer Rosenthal McGlynn's 13F filing for Q2 2015, filed 14 Aug 2015.